Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jeremy Shefner, MD, PhD
State University of New York - Upstate Medical University
Study ChairKOL profile → - Jeremy Shefner, MD, PhD
State University of New York - Upstate Medical University
Principal InvestigatorKOL profile →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
75 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Heritage Medical Research
Calgary, Alberta, Canada
- University of Alberta Hospital
Edmonton, Alberta, Canada
- University of British Columbia
Vancouver, British Columbia, Canada
- Stan Cassidy Centre for Rehabilitation
Fredericton, New Brunswick, Canada
- Qe Ii Health Sciences Centre
Halifax, Nova Scotia, Canada
- Mcmaster University Medical Centre
Hamilton, Ontario, Canada
- Queen'S University : Kingston General
Kingston, Ontario, Canada
- London Health Sciences
London, Ontario, Canada
- Univ. of Toronto - Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Hôpital Notre Dame (chum) Centre Hospitalier de L'Universite de Montreal
Montreal, Quebec, Canada
- Montreal Neurological Institute
Montreal, Quebec, Canada
- Chu de Quebec: Hopital L'Enfant-Jesus
Québec, Quebec, Canada
- Chru de Lille - Hôpital Roger Salengro
Lille, France
- Chu de Limoges - Hôpital Dupuytren
Limoges, France
- Hôpital la Timone Adulte
Marseille, France
- Chu Montepellier
Montpellier, France
- Hôpital Archet 1
Nice, France
- Hôpital de la Salpêtrière
Paris, France
- Hôpital Bretonneau
Tours, France
- Charite Universitätsmedizin
Berlin, Germany
- Hannover Medical School
Hanover, Germany
- University of Ulm
Ulm, Germany
- Trinity College, Beaumont Hospital
Dublin, Ireland
- Universitair Medisch Centrum Utrecht
Utrecht, Netherlands
- Hospital Carlos Iii
Madrid, Spain
- Barts and the London Mnd & the Centre Royal London Hospital
Whitechapel, London, United Kingdom
- Walton Centre for Neurology and Neurosurgery
Liverpool, United Kingdom
- Kings College Hospital Nhs Foundation Trust
London, United Kingdom
- John Radcliffe Hospital
Oxford, United Kingdom
- Plymouth Hospitals Nhs Trust
Plymouth, United Kingdom
- Sheffield Institute for Translational Neuroscience
Sheffield, United Kingdom
- Barrow Neurology
Phoenix, Arizona, United States
- University of California, San Diego
La Jolla, California, United States
- Uc Irvine Als & Neuromuscular Center
Orange, California, United States
- Coordinated Clinical Research
San Diego, California, United States
- California Pacific Medical Center Forbes Norris Mda/als Research Center
San Francisco, California, United States
- Hospital for Special Care
New Britain, Connecticut, United States
- the George Washington University
Washington D.C., District of Columbia, United States
- Mayo Clinic Florida Department of Neurology
Jacksonville, Florida, United States
- Emory University, School of Medicine
Atlanta, Georgia, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2012
- Primary completion
- 31 Mar 2014
- Completion
- 31 Mar 2014
- Last update posted
- 31 Mar 2020
- Registered enrollment
- 711
- Registry id
- NCT01709149
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.